Episode Details
Back to Episodes
Ep 81: IGNYTE trial (RP1 + nivo)
Season 3
Episode 81
Published 4 months ago
Description
SummaryThe conversation covers the published data from the IGNYTE study - RP1 + nivolumab: response rate and safety profile, RNA-seq analysis, and toxicity. The key takeaways include insights into clinical trial interpretation and treatment efficacy (and incorrect graphs).Takeaways
- Clinical Trial Data
- Treatment Efficacy
Chapters
- 00:00 Introduction to IGNYTE Study
- 14:04 Response Rate and Safety Profile
- 25:17 RNA-seq Analysis and Toxicity